Donna Snyder, MD, MBE
Executive Physician, WCG
Biography
Donna Snyder, MD, MBE, is the executive physician at WCG providing guidance on medicine, research, and regulations. Before WCG, Dr. Snyder served as senior pediatric ethicist, in the Office of Pediatric Therapeutics, at the Food and Drug Administration (FDA). She is a board-certified pediatrician with experience in pediatric practice and research ethics.
Latest insights by Donna
FDA Guidance on AI-Enabled Devices: Transparency, Bias, & Lifecycle Oversight
Blog Posts
Pioneering Ethical Oversight in AI-Enabled Clinical Research: Insights on the New Framework
Blog Posts
Review of the FDA Draft Guidance: Considerations for Including Tissue Biopsies in Clinical Trials
Blog Posts
The Role of AI in Regulatory Decision-Making for Drugs & Biologics: the FDA’s Latest Guidance
Blog Posts
The FDA Accepts ICH E11A on Pediatric Extrapolation: How Does This Impact Your Pediatric Study?
Blog Posts
Unpacking the FDA’s Guidance on Developing Drugs for Treatment in Pediatric Inflammatory Bowel Disease
Blog Posts
Demystifying FDA Processes: Why Do Changes in Regulations Take so Long?
Blog Posts
Ethical Review & AI in Clinical Trials
Podcasts